Popular assessment tool a poor predictor of cardiovascular risk in rheumatoid arthritis patients Novel drug shows promise in rheumatoid arthritis Predictors of hip disease risk found in juvenile arthritis Rheumatoid arthritis care remains suboptimal Canadian study suggests early, aggressive treatment has not caught on in primary care, especially DMARDs Possible link found between rheumatoid arthritis biologics and certain skin cancers Overall risk remains low, but increased incidences seen with anti-tumour necrosis factor drugs CE Lesson: Update On Rheumatoid Arthritis Gene therapy not to blame in woman's death New biologic approved for RA, psoriatic arthritis and ankylosing spondylitis Schering-Plough has received Health Canada approval to market Simponi (golimumab) subcutaneous injection. Focus on Alcohol Abuse: The Role of the Pharmacist Pain and mobility issues with OA First Previous 20 21 22 Next Last
